Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
Article 2017 en
Authors
MP
Milton Packer
CO
Christopher M. O’Connor
JM
John J.V. McMurray
Abstract
1 min read
In patients with acute heart failure, ularitide exerted favorable physiological effects (without affecting cardiac troponin levels), but short-term treatment did not affect a clinical composite end point or reduce long-term cardiovascular mortality. (Funded by Cardiorentis; TRUE-AHF ClinicalTrials.gov number, NCT01661634 .).
Johannes Grand, Kristina Miger, Ahmad Sajadieh, Lars Køber, Christian Torp‐Pedersen, Georg Ertl, José López‐Sendón, Aldo Maggioni, John R. Teerlink, Naoki Sato, Claudio Gimpelewicz, Marco Metra, Thomas Holbro, Olav Wendelboe Nielsen
Johannes Grand, Kristina Miger, Ahmad Sajadieh, Lars Køber, Christian Torp‐Pedersen, Georg Ertl, JL. Lopez Sendon, Aldo Maggioni, Olav Wendelboe Nielsen
Johannes Grand, Kristina Miger, Ahmad Sajadieh, Lars Køber, Christian Torp‐Pedersen, Georg Ertl, José López‐Sendón, Aldo Maggioni, Olav Wendelboe Nielsen
Fabrizio Oliva, Andrea Mortara, Giuseppe Cacciatore, Alessandra Chinaglia, Andrea Di Lenarda, Marco Gorini, Marco Metra, Michele Senni, Aldo Maggioni, Luigi Tavazzi
Discussion(0)
No comments yet. Be the first to comment.